Ningqingtuo^® Nifedipine Extended-Release Tablets are dihydropyridine calcium channel blockers, indicated for the treatment of hypertension, coronary artery disease, and stable chronic angina (exertional angina). The pharmacological actions include: ①Dilating the coronary arteries. ② Reducing the tension of coronary artery smooth muscle, preventing vasospasm, increasing blood flow to narrowed vessels, and improving oxygen supply. Additionally, by lowering peripheral resistance, it reduces oxygen demand. Long-term use of nifedipine helps prevent the development of new coronary atherosclerotic lesions. ③Both short-term and long-term use of nifedipine increase sodium and water excretion. As a result, nifedipine has particularly effective antihypertensive properties for patients with high blood pressure.

Ningqingtuo^® Nifedipine Extended-Release Tablets, compared to “regular tablets” and “extendeded-release tablets,” offer several key advantages: a more stable drug release rate, a smoother and more consistent antihypertensive effect, fewer side effects, longer-lasting efficacy, greater convenience in administration, and improved patient adherence. It matches the original product in terms of efficacy and quality and has passed the generic drug consistency evaluation, making it ideal for patients requiring long-term hypertension treatment.